Skip to main content
Sign In
 

Amanda Winters, MD, PhD

Clinical Fellow


I am a clinical fellow in Pediatric Hematology/Oncology at Children’s Hospital Colorado, and am continuing my basic science training in the Jordan lab. My project involves characterization of chemo-resistant cell populations in acute myeloid leukemias (AML), with the ultimate goal of identifying effective targeted therapies for residual disease. An additional goal of my research is to develop more sensitive and specific assays for detection of minimal residual disease (MRD) in patients with no clinically apparent disease.

Currently I am working with adult primary AML samples, which I am analyzing with mass cytometry and with targeted sequencing of a panel of AML-associated genes.  Mass cytometry allows us to look at >20 cell surface markers and intracellular phosphorylated signaling proteins simultaneously, which in turn allows us to identify individual subpopulations within an AML sample and track their relative abundances during initial chemotherapy. We can then isolate the subpopulations which are most resistant to standard chemotherapies and can study their genetic mutational profiles and sensitivities to targeted drug therapies. We can also use the genotypic information to identify candidate mutations for MRD monitoring via droplet digital PCR, with the goal of detecting molecular evidence of disease at earlier timepoints prior to clinical relapse. An additional goal of my time in the lab is to extend these studies to pediatric AML.

Tel: 303-724-8232​